Cortical thinning is associated with disease stages and dementia in Parkinson's Disease

dc.contributor.authorZarei, Mohammad
dc.contributor.authorIbarretxe Bilbao, Naroa
dc.contributor.authorCompta, Yaroslau
dc.contributor.authorHough, Morgan
dc.contributor.authorJunqué i Plaja, Carme, 1955-
dc.contributor.authorBargalló Alabart, Núria
dc.contributor.authorTolosa, Eduardo
dc.contributor.authorMartí Domènech, Ma. Josep
dc.date.accessioned2026-01-30T13:42:34Z
dc.date.available2026-01-30T13:42:34Z
dc.date.issued2013-03-05
dc.date.updated2026-01-30T13:42:34Z
dc.description.abstractObjective: To investigate the pattern of cortical thinning in Parkinson's disease (PD) across different disease stages and to elucidate to what extent cortical thinning is related to cognitive impairment. Design: Ninety-six subjects including 39 controls and 57 PD patients participated in this study. PD subjects were divided into three groups (early, n=24; moderate, n=18; with dementia, n=15). High field structural brain MRI images were acquired in a 3T scanner and analyses of cortical thickness and surface were carried out. Vertex-wise group comparisons were performed and cortical thickness was correlated with motor and cognitive measures. Results: We found a positive correlation between Mini-Mental State Examination scores and cortical thickness in the anterior temporal, dorsolateral prefrontal, posterior cingulate, temporal fusiform and occipitotemporal cortex. Unified Parkinson's Disease Rating Scale-III (motor subsection) scores showed a robust negative correlation with caudate volumes. We found that disease stage in PD was associated with thinning of the medial frontal (premotor and supplementary motor cortex), posterior cingulate, precuneus, lateral occipital, temporal and dorsolateral prefrontal cortex. Discriminant analysis and a receiver operating characteristics approach showed that mean cortical thickness and hippocampus volume have 80% accuracy in identifying PD patients with dementia. PD stage and PD dementia can be characterised by a specific pattern of cortical thinning. Conclusions: We conclude that measuring cortical thickness can be useful in assessing disease stage and cognitive impairment in patients with PD. In addition, cortical thickness may be useful in identifying dementia in PD.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec620554
dc.identifier.issn0022-3050
dc.identifier.pmid23463873
dc.identifier.urihttps://hdl.handle.net/2445/226499
dc.language.isoeng
dc.publisherBritish Medical Journal
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1136/jnnp-2012-304126
dc.relation.ispartofJournal of Neurology Neurosurgery and Psychiatry, 2013, vol. 84, num.8, p. 875-881
dc.relation.urihttps://doi.org/10.1136/jnnp-2012-304126
dc.rightscc-by-nc (c) Zarei, Mohammad, et al., 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.classificationMalaltia de Parkinson
dc.subject.classificationDemència
dc.subject.classificationImatges per ressonància magnètica
dc.subject.otherParkinson's disease
dc.subject.otherDementia
dc.subject.otherMagnetic resonance imaging
dc.titleCortical thinning is associated with disease stages and dementia in Parkinson's Disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
160447.pdf
Mida:
334.87 KB
Format:
Adobe Portable Document Format